Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
PBI-4050 reduces stellate cell activation and liver fibrosis through modulation of intracellular ATP levels and LKB1-AMPK-mTOR pathway
Brigitte Grouix, Francois Sarra-Bournet, Martin Leduc, Jean-Christophe Simard, Kathy Hince, Lilianne Geerts, Alexandra Blais, Liette Gervais, Alexandre Laverdure, Alexandra Felton, Jonathan Richard, Jugurtha Ouboudinar, William Gagnon, Francois Leblond, Pierre Laurin and Lyne Gagnon
Journal of Pharmacology and Experimental Therapeutics August 9, 2018, jpet.118.250068; DOI: https://doi.org/10.1124/jpet.118.250068
Brigitte Grouix
Prometic Biosciences
Francois Sarra-Bournet
Prometic Biosciences
Martin Leduc
Prometic Biosciences
Jean-Christophe Simard
Prometic Biosciences
Kathy Hince
Prometic Biosciences
Lilianne Geerts
Prometic Biosciences
Alexandra Blais
Prometic Biosciences
Liette Gervais
Prometic Biosciences
Alexandre Laverdure
Prometic Biosciences
Alexandra Felton
Prometic Biosciences
Jonathan Richard
Prometic Biosciences
Jugurtha Ouboudinar
Prometic Biosciences
William Gagnon
Prometic Biosciences
Francois Leblond
Prometic Biosciences
Pierre Laurin
Prometic Biosciences
Lyne Gagnon
Prometic Biosciences
Data Supplement
- Supplemental Figures -
Figures S1-S4.